Laminate


Invest with us
Tammy Gilon
Tel: +972.54.7582590
E-mail: tammy@laminatemedical.com
Our Team
  • Tammy Gilon, B.Sc CEO & Co-founder
  • Eyal Orion, MD, MBA. Co-founder
  • For more Information please visit:

    http://www.laminatemedical.com/

  • FDA Approval
  • CE Mark
  • Clinical Studies
  • Design Freeze & Prototype Production
  • Pre-Clinical Studies
  • Concept Design & Engineering

  • Laminate Medical is developing a solution that will improve care for dialysis patients. Currently, the preferred method of hemodialysis is through a surgically connected artery or vein, called an arteriovenous fistula. Unfortunately, 40% of arteriovenous fistula  fail within one year, becoming blocked (patency). Laminate has developed a device to improve vascular access patency rates in hemodialysis patients.

    Market

    More than 550,000 people suffer from kidney failure in the U.S.

    200,000 fistula procedures are performed in the U.S. annually.

    Cost of fistula failures to the U.S health system are over $1 billion per year